Article Menu

Export Article

More by Authors Links

Article Data

  • Views 1679
  • Dowloads 134

Original Research

Open Access

The 21st century role of Piver type II hysterectomy in FIGO Stage IA, IB cervical cancer: A personal perspective

  • M.S. PIVER1,*,
  • J.Y. Lee1

1Department of Obstetrics and Gynecology, Sisters of Charity Hospital, Buffalo, NY, USA

DOI: 10.12892/ejgo200802109 Vol.29,Issue 2,March 2008 pp.109-113

Published: 10 March 2008

*Corresponding Author(s): M.S. PIVER E-mail:

PDF (163.6 kB) View Full-text

Abstract

Class II modified radical hysterectomy reported in 1974 by Piver, Rutledge and Smith for cervical cancer is an extended hysterectomy that has less dissection of the ureter from the paracervical tissues, ligation of the uterine vessels just medial to the ureter to ensure preservation of the distal ureteral blood supply, and less radical parametrectomy preserving the lateral parametrium. The authors present a 21(st) century personal perspective on the use of a type II hysterectomy based on the 1994 FIGO changes in classification of Stage IAI, IA2, IBI and IB2.

Cite and Share

M.S. PIVER,J.Y. Lee. The 21st century role of Piver type II hysterectomy in FIGO Stage IA, IB cervical cancer: A personal perspective. European Journal of Gynaecological Oncology. 2008. 29(2);109-113.

URL:

https://www.ejgo.net/articles/10.12892/ejgo200802109

References

[1] Sankaranarayanan R.: “Worldwide burden of gynaecological cancer: The size of the problem”. Clinical Obstet. Gynaecol., 2006, 20, 207.

[2] Wertheim E.: “Zur Frage der Radikaloperation beim Uteruskrebs”. Arch. Gynacol., 1900, 61, 627.

[3] Meigs J.V.: “Radical hysterectomy with bilateral pelvic lymph node dissection: a report of 100 patients operated on five or more years ago”. Am J. Obstet. Gynecol., 1951, 62, 854.

[4] Piver M.S., Rutledge F., Smith J.P.: “Five classes of extended hysterectomy for women with cervical cancer”. Obstet. Gynecol., 1974, 44, 215.

[5] Piver M.S., Rose P.G., Freedman M.F.: “Changes in FIGO staging”. Am. J. Obstet. Gynecol., 1988, 158, 678.

[6] Ostor A.G., Romere: “Microinvasive squamous cell carcinoma of the cervix: A clinical pathologic study of 200 cases with long term followup”. Int. J. Gynecol. Cancer, 1994, 4, 257.

[7] Benedet J.L., Anderson G.H.: “Stage IA carcinoma of the cervix revisited”. Obstet. Gynecol., 1996, 87, 1052.

[8] Piver M.S., Chung W.S.: “Prognostic significance of cervical lesion size and pelvic lymph node metastasis in cervical carcinoma”. Obstet. Gynecol., 1975, 46, 507.

[9] Landoni F., Maneo A., Cormio G. et al.: “Class II versus class III radical hysterectomy in Stage IB-IIA cervical cancer: A prospective randomized study”. Gynecol. Onccol., 2001, 80, 3.

[10] Hoffman M.S.: “Extent of radical hysterectomy: Evolving emphasis”. Gynecol. Oncol., 204, 94, 1.

[11] Raspagliesi F., Ditto A., Fontanelli R. et al.: “Type II versus type III nerve sparing radical hysterectomy: Comparison of lower urinary tract dysfunctions”. Gynecol. Oncol., 2006, 102, 256.

[12] Abu-Rustum N.R., Sonoda Y.: “Fertility sparing radical abdominal trachelectomy for cervical carcinoma. Gynecol Oncol, 2007, 104:S56.

[13] Sert B.M., Abeler V.M.: “Robotic-assisted laparoscopic hysterectomy (Piver type III) with pelvic node dissection - a case report”. Eur. J. Gynecol. Oncol., 2006, 27, 531.

[14] Yessaian A., Magistris., Burger R.A., Monk B.J.: “Radical hysterectomy followed by tailored postoperative therapy in the treatment of Stage IB2 cervical cancer: feasibility and indications for adjuvant therapy”. Gynecol. Oncol., 2004, 94, 61.

Submission Turnaround Time

Top